A Comparison of Postelimination Measles Epidemiology in the United States, 2009-2014 Versus 2001-2008
- PMID: 26666559
- PMCID: PMC4905815
- DOI: 10.1093/jpids/piv080
A Comparison of Postelimination Measles Epidemiology in the United States, 2009-2014 Versus 2001-2008
Abstract
Background: Measles, a vaccine-preventable disease that can cause severe complications, was declared eliminated from the United States in 2000. The last published summary of US measles epidemiology was during 2001-2008. We summarized US measles epidemiology during 2009-2014.
Methods: We compared demographic, vaccination, and virologic data on confirmed measles cases reported to the Centers for Disease Control and Prevention during January 1, 2009-December 31, 2014 and January 1, 2001-December 31, 2008.
Results: During 2009-2014, 1264 confirmed measles cases were reported in the United States, including 275 importations from 58 countries and 66 outbreaks. The annual median number of cases and outbreaks during this period was 130 (range, 55-667 cases) and 10 (range, 4-23 outbreaks), respectively, compared with an annual median of 56 cases (P = .08) and 4 outbreaks during 2001-2008 (P = .04). Among US-resident case-patients during 2009-2014, children aged 12-15 months had the highest measles incidence (65 cases; 8.3 cases/million person-years), and infants aged 6-11 months had the second highest incidence (86 cases; 7.3 cases/million person-years). During 2009-2014, 865 (74%) of 1173 US-resident case-patients were unvaccinated and 188 (16%) had unknown vaccination status; of 917 vaccine-eligible US-resident case-patients, 600 (65%) were reported as having philosophical or religious objections to vaccination.
Conclusions: Although the United States has maintained measles elimination since 2000, measles outbreaks continue to occur globally, resulting in imported cases and potential spread. The annual median number of cases and outbreaks more than doubled during 2009-2014 compared with the earlier postelimination years. To maintain elimination, it will be necessary to maintain high 2-dose vaccination coverage, continue case-based surveillance, and monitor the patterns and rates of vaccine exemption.
Keywords: epidemiology; measles; measles elimination; measles mumps rubella (MMR) vaccine.
Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Conflict of interest statement
Figures
Similar articles
-
Measles in the United States during the postelimination era.J Infect Dis. 2010 Nov 15;202(10):1520-8. doi: 10.1086/656914. Epub 2010 Oct 7. J Infect Dis. 2010. PMID: 20929352
-
Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis.JAMA. 2016 Mar 15;315(11):1149-58. doi: 10.1001/jama.2016.1353. JAMA. 2016. PMID: 26978210 Free PMC article. Review.
-
International Importations of Measles Virus into the United States During the Postelimination Era, 2001-2016.J Infect Dis. 2019 Apr 19;219(10):1616-1623. doi: 10.1093/infdis/jiy701. J Infect Dis. 2019. PMID: 30535027 Free PMC article.
-
Epidemiology of two large measles virus outbreaks in Catalonia: what a difference the month of administration of the first dose of vaccine makes.Hum Vaccin Immunother. 2013 Mar;9(3):675-80. doi: 10.4161/hv.23265. Epub 2013 Jan 9. Hum Vaccin Immunother. 2013. PMID: 23303107 Free PMC article.
-
Measles, mumps, rubella prevention: how can we do better?Expert Rev Vaccines. 2021 Jul;20(7):811-826. doi: 10.1080/14760584.2021.1927722. Epub 2021 Jun 7. Expert Rev Vaccines. 2021. PMID: 34096442 Review.
Cited by
-
MMR Vaccine Adverse Drug Reactions Reports in the CDC WONDER System, 1989-2019.Open Forum Infect Dis. 2020 Aug 12;7(8):ofaa211. doi: 10.1093/ofid/ofaa211. eCollection 2020 Aug. Open Forum Infect Dis. 2020. PMID: 32818137 Free PMC article.
-
Clinical Practices for Measles-Mumps-Rubella Vaccination Among US Pediatric International Travelers.JAMA Pediatr. 2020 Feb 1;174(2):e194515. doi: 10.1001/jamapediatrics.2019.4515. Epub 2020 Feb 3. JAMA Pediatr. 2020. PMID: 31816033 Free PMC article.
-
Forecasted Size of Measles Outbreaks Associated With Vaccination Exemptions for Schoolchildren.JAMA Netw Open. 2019 Aug 2;2(8):e199768. doi: 10.1001/jamanetworkopen.2019.9768. JAMA Netw Open. 2019. PMID: 31433482 Free PMC article.
-
Measles and Rubella Seroprevalence in Mother-Infant Pairs in Rural Nepal and the United States: Pre- and Post-Elimination Populations.Am J Trop Med Hyg. 2018 Nov;99(5):1342-1345. doi: 10.4269/ajtmh.17-0836. Am J Trop Med Hyg. 2018. PMID: 30403166 Free PMC article.
-
Measles vaccination in an increasingly immunized and developed world.Hum Vaccin Immunother. 2019;15(1):28-33. doi: 10.1080/21645515.2018.1517074. Epub 2018 Sep 19. Hum Vaccin Immunother. 2019. PMID: 30156949 Free PMC article. Review.
References
-
- Strebel PM, Papania MJ, Parker Fiebelkorn A, Halsey NA. Measles Vaccine. In: Plotkin SA, Orenstein WA, Offit P, editors. Vaccines. 6 ed. Elsevier Saunders; 2013. pp. 352–387.
-
- McLean HQ, Fiebelkorn AP, Temte JL, Wallace GS. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 2013;62(RR-04):1–34. - PubMed
-
- Centers for Disease C. School immunization requirements for measles--United States, 1982. MMWR Morb Mortal Wkly Rep. 1982;31(6):65–67. - PubMed
-
- Katz SL, Hinman AR. Summary and conclusions: measles elimination meeting, 16–17 March 2000. J Infect Dis. 2004;189(Suppl 1):S43–S47. - PubMed
-
- Papania MJ, Wallace GS, Rota PA, et al. Elimination of endemic measles, rubella, and congenital rubella syndrome from the Western hemisphere: the US experience. JAMA pediatrics. 2014;168(2):148–155. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical